• <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    来宝网Logo

    热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置首页>技术资料首页>行业动态>公司动态>Thermo Fisher 收购Ahura Scientific

    Thermo Fisher 收购Ahura Scientific

    Thermo Fisher2010年1月28日 9:29 点击:2928

    美国赛默飞世尔科技 Thermo Fisher Scientific  美国Ahura Scientific
    Thermo Fisher 收购Ahura Scientific
    (TMO) 47.75 : Thermo FISher同意以1.45亿美元现金收购Ahura SCientific,另外根据2010年财务目标达成率,可能给付红利。

    赛默飞世尔科技签约收购手持式分光计领域的领先创新企业 Ahura Scientific

    2010 年 1 月 27 日 ,中国上海 ——服务科学领域的全球领导者赛默飞世尔科技公司(纽约证交所代码 :TMO )近日宣?#35745;?#24050;签署收购 Ahura Scientific 公司的最终协议,收购价格为 1.45 亿元现金加上基于某些 2010 财务目标的潜在“获利能力付款”。 Ahura Scientific 是一家为人类健康和公共安全提供现场分析仪的领先企业,其产品丰富了赛默飞世尔的便携式分析仪产品线,令客户能在现场快速鉴别各种分子和元素物质。 Ahura Scientific 总部 位于马萨诸塞州的威明顿,拥有近 120 名员工, 2009 年全年营业总收入接近 4500 万元。

    Ahura Scientific 专注于化学成分的鉴别,其产品适用于安全和制药领域。公司坚固耐用的小型 Raman 和 FT-IR (傅立叶变换 红外 光谱)光谱仪器广泛用于军方和民间第一反应者、主要制药厂商和消费者健康组织。 Ahura Scientific 的产品补充了赛默飞世尔的便携式 XRF ( X 射线荧光)元素分析仪产品线,可在现场对材料进行快速测试,适用于许多应用领域,包括金属和合金分析、质量保证和控制、消费者产品安全和环境分析。

    “收购 Ahura Scientific 为我们带来了补充技术、扩大了我们的产品线,从而进一步增强了我们在手持式分析仪领域的地位和 Thermo Scientific 品牌。”赛默飞世尔科技总裁兼首席执行官 Marc N. Casper 说道:“这一收购行动还能使我们充分利用我们在多用途实验室和便携式仪器平台方面的商业渠道、产品开发专业知识和软件。此次合并将双方在便携式化学和元素分析方面的先进技术结?#26174;?#19968;起,使我们能为客户制造功能?#30475;蟆?#21487;在现场进行实验室级别分析的工具。

    Ahura Scientific 董事?#31181;?#24109;兼首席执行官 Doug Kahn 说道:“ Ahura Scientific 的所有员工对于加入赛默飞世尔都感到十分激动。此次合并使得两家公司在产?#39134;?#23454;现了互补,追求一致的公司使命,这对双方来说都是一个理想的、合理的战略行动。”

    此次收购交?#33258;?#35745;于 2010 年第一季度结束。该收购交易需通过适用的监管审批,并进行惯例的结算后收购价格调整。 Ahura Scientific 将并入赛默飞世尔的分析技术分部。公司认为此次交易不会对其 2010 年财务成果造成重大影响。

    关于 Thermo Fisher Scientific (赛默飞世尔科技)

    赛默飞世尔科技 ( Thermo Fisher Scientific) (纽约证交所代码: TMO )是全球科学服务领域的领导者,致力于帮助客户使世界更健康、更清洁、更安全。公司年销售额超过 105 亿美元,拥有员工约 3 万 4 千人,在全球范围内服务超过 35 万家客户。主要客户类型包括:医药和生物公司,医院和临床诊断实验室,大学、科研院所和政府机构,?#32422;?#29615;境与工业过程控制装备制造商等。公司借助于 Thermo Scientific 和 Fisher Scientific 这两个主要的品牌,帮助客户解决在分析化学领域所遇到的从常规测试到复杂研发的各种挑?#20581;?Thermo Scientific 能够为客户提供一整套包括高端分析仪器、实验室装备、软件、服务、耗材和?#32422;?#22312;内的实验室综合解决方案。 Fisher Scientific 为卫生保健、科学研究、安全和教育领域的客户提供一系列实验室装备、化学药品及其他用品和服务。赛默飞世尔科技将努力为客户提供最为便捷的采购方案,为科学研究的飞速发展?#27426;?#25913;进工艺技术,提升客户价值,帮助股东提高收益,为员工创造良好的发展空间。更多信息 , 请浏览公司网站 : www.thermofisher.comwww.thermo.com.cn

    关于 Ahura Scientific, Inc.

    Ahura Scientific 致力于为现场检测提供实验室精度水平的分析。公司的现场分析仪可为人类健康和公共安全专家持续提供精确的、可指导行动的信息。 Ahura Scientific 已获得行业领先的风险投资公司的支持,包括 Fuse Capital 、 Castile Ventures 和 ARCH Venture Partners 。 Castile Ventures 为其主要投资人,与创业团队一起以未来愿景为核心创建公司,为公司解决关键客户的需求提供了极大的支持和指导。公司的 FirstDefender (R) 、 TruDefender(TM) FT 、 TruDefender FTG 、 TruScan(TM) 和 TruScreen(TM) 产品广泛应用于全球范围内的国土安全、公共安全、制药、工业和医疗市场。 Ahura Scientific 成立于 2002 年 , 总部位于马萨诸塞州的威明顿。更多信息 , 请访问 http://www.ahurascientific.com



    Thermo Fisher新闻稿

    Thermo Fisher Scientific Signs Agreement to Acquire Leading Innovator in Handheld Spectrometers, Ahura Scientific
    WALTHAM, Mass., Jan 19, 2010 (BUSINESS WIRE) -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has signed a definitive agreement to acquire Ahura Scientific, a leader in field-deployed analytical instruments for human health and public safety, for $145 million in cash plus the potential for an earn-out payment based on the achievement of certain 2010 financial targets. Ahura Scientific's products expand Thermo Fisher's portfolio of portable analytical devices designed to provide customers with the ability to rapidly identify and authenticate a range of molecular and elemental substances in the field. Based in Wilmington, Mass., Ahura Scientific has approximately 120 employees and generated full-year revenue of approximately $45 million in 2009.

    Ahura Scientific specializes in the identification of chemicals for safety, security and pharmaceutical applications. The company's rugged, miniaturized Raman and FT-IR (Fourier-transform infrared) spectroscopy instruments are used worldwide by military and civilian first responders, major pharmaceutical manufacturers and consumer health organizations. Ahura Scientific products complement the Thermo Scientific line of portable XRF (X-ray fluorescence) elemental analyzers, which are designed for rapid on-site testing of materials for numerous applications, including metal and alloy analysis, quality assurance and control, consumer product safety and environmental analysis.

    "The acquisition of Ahura Scientific further enhances our position in handheld analyzers and strengthens our Thermo Scientific brand by expanding the breadth of our portfolio with complementary technologies," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. "It also provides the ability to leverage our commercial channel, product development expertise, and software over multiple laboratory and portable instrument platforms. This combination brings together both companies' leading technologies for portable chemical and elemental analysis, allowing us to create a powerful tool set for our customers that enables laboratory-quality analysis in the field."

    Doug Kahn, chairman and chief executive officer of Ahura Scientific, said, "The entire Ahura Scientific team is excited to be joining the Thermo Fisher organization. The complementary products and mission make this an ideal and logical strategic fit for both companies."

    The transaction, which is expected to close during the first quarter of 2010, is subject to applicable regulatory approvals and a customary post-closing purchase price adjustment. Ahura Scientific will be integrated into Thermo Fisher's Analytical Technologies Segment. The company does not expect this transaction to have a material impact on its 2010 financial results.

    About Thermo Fisher Scientific

    Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With 2008 revenues of $10.5 billion, we have approximately 35,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit http://www.thermofisher.com.

    About Ahura Scientific, Inc.

    Ahura Scientific is dedicated to bringing lab-accurate analysis directly to the point of need. The company's field-deployed analytical instruments consistently deliver precise and actionable intelligence to human health and public safety specialists. Ahura Scientific has been backed by leading venture capital firms, including Fuse Capital, Castile Ventures and ARCH Venture Partners. Castile Ventures, serving as lead investor, worked with the founding team to establish the company around their far-reaching vision and has been instrumental in supporting and guiding the company as it addressed critical customer needs. The company's FirstDefender(R), TruDefender(TM) FT, TruDefender FTG, TruScan(TM) and TruScreen(TM) are deployed worldwide in the homeland security, public safety, pharmaceutical, industrial and medical markets. Founded in 2002, Ahura Scientific is headquartered in Wilmington, Mass. For more information, visit http://www.ahurascientific.com.

    The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's Quarterly Report on Form 10-Q for the period ended September 26, 2009, under the caption "Risk Factors," which is on file with the Securities and Exchange Commission and available in the "Investors" section of our Website under the heading "SEC Filings." Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: competition and its effect on pricing, spending, third-party relationships and revenues; the need to develop new products and adapt to significant technological change; implementation of strategies for improving internal growth; general worldwide economic conditions and related uncertainties; dependence on customers' capital spending policies and government funding policies; the effect of exchange rate fluctuations on international operations; use and protection of intellectual property; the effect of changes in governmental regulations; the effect of laws and regulations governing government contracts; the effect of competing with certain of our customers and suppliers; and the effect of rapid changes in the healthcare industry. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so even if our estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.

    SOURCE: Thermo Fisher Scientific Inc.

    Thermo Fisher Scientific Inc.
    Media Contact Information:
    Ron O'Brien, 781-622-1242
    [email protected]
    http://www.thermofisher.com
    or
    Investor Contact Information:
    Ken Apicerno, 781-622-1294
    [email protected]

    (来源: Thermo Fisher )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://www.67994619.com,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他?#25945;濉?#32593;站或个人从本网转载?#20445;?#24517;须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为?#29260;?#30456;关权利。


    云南11选5技巧
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    18选7开奖结果今天 新疆11选511号下午推荐 时时彩软件 陕西快乐十分中奖票 体育彩票广东时时彩 特肖平特肖什么意思 幸运飞艇是正规福彩吗 海南环岛赛吉祥物 福建11选5助手免费版 安徽11选五开奖号码一定牛 七位数200期走势图 体彩7星彩几个数能兑奖 真人龙虎斗网址 竞彩篮球胜分差怎么玩 丁俊晖最新比赛时间表